CSCI/CITAC Young Investigators Forum Abstracts

August 2010
Clinical & Investigative Medicine;Aug2010, Vol. 33 Issue 4, preceding p1
Academic Journal
The article presents abstracts on medical topics which include the role of natural killer cells in the induction of chimerism, the development of a stem cell delivery system for treating retinal degenerative diseases, and the impact of chemotherapy on oncolytic virus-induced anti-leukemia immunity.


Related Articles

  • Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Ribeiro, Andreia; Laranjeira, Paula; Mendes, Sandrine; Velada, Isabel; Leite, Cristiana; Andrade, Pedro; Santos, Francisco; Henriques, Ana; Grãos, Mário; Cardoso, Carla; Martinho, António; Pais, MLuísa; Da Silva, Cláudia Lobato; Cabral, Joaquim; Trindade, Hélder; Paiva, Artur // Stem Cell Research & Therapy;2013, Vol. 4 Issue 5, p1 

    Introduction The ability to self-renew, be easily expanded in vitro and differentiate into different mesenchymal tissues, render mesenchymal stem cells (MSCs) an attractive therapeutic method for degenerative diseases. The subsequent discovery of their immunosuppressive ability encouraged...

  • High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies. Kwong, Y.-L. // Bone Marrow Transplantation;Dec2009, Vol. 44 Issue 11, p709 

    Natural killer (NK)-cell lymphomas are aggressive. Patients with early (stage I/II) diseases respond favorably to radiotherapy and chemotherapy. Patients with relapses and advanced (stage III/IV) diseases have poor outcome. To improve treatment results, high-dose chemotherapy with hematopoietic...

  • Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation. Nawa, Y; Takenaka, K; Shinagawa, K; Deguchi, S; Matsumura, N; Koyama, S; Hiramatsu, Y; Omoto, E; Yoshino, T; Harada, M // Bone Marrow Transplantation;6/15/99, Vol. 23 Issue 12, p1321 

    CD56+ angiocentric lymphoma has currently been recognized as a distinct clinical entity which is the prototype of the putative NK cell lymphomas. A 16-year-old Japanese girl with advanced CD56+ angiocentric lymphoma received high-dose chemotherapy supported with syngeneic peripheral blood stem...

  • Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. A-Reum Han; Hye Lee; Byeong-Bae Park; In Hwang; Sarah Park; Sang Lee; Kihyun Kim; Ho Lim; Young Ko; Sun Kim; Won Kim // Annals of Hematology;Jul2007, Vol. 86 Issue 7, p493 

    The clinical features and prognostic factor of lymphoma-associated hemophagocytic syndrome (LAHS), diagnosed according to World Health Organization classification, were investigated by reviewing the clinical records of 29 patients between September 1994 and September 2006. Compared with patients...

  • Stem cells: Hidden talents. Bussell, Katrin // Nature Reviews Molecular Cell Biology;Aug2003, Vol. 4 Issue 8, p596 

    Discusses the effectiveness of Wnt signalling in treating neuromuscular degenerative disease. Increase in the proportion of cells expressing CD45 and stem cell antigen-1 in regenerating tissues compared to uninjured cells; Proliferation of myoblasts; Relevance of Wnt signalling in in vivo.

  • Stem cells and degenerative diseases. de Carvalho, Antonio Carlos // BMC Proceedings;10/1/2014, p1 

    An abstract of the article "Stem cells and degenerative diseases" by Antonio Carlos de Carvalho is presented.

  • The interval between courses of high-dose chemotherapy with stem cell rescue: therapeutic hypotheses. Frei III, E; Richardson, P; Avigan, D; Bunnell, C; Wheeler, C; Elias, A // Bone Marrow Transplantation;11/1/99, Vol. 24 Issue 9, p939 

    The interval between courses of chemotherapy have classically been kept to a minimum in order to maximize dose intensity. Certain clinical observations suggest that longer intervals, particularly in the high-dose setting, may be more effective. This is based in part on the evidence that...

  • Generation of dopaminergic neurons from embryonic stem cells. Sasai, Yoshiki // Journal of Neurology;Sep2002 Supplement 2, Vol. 249, pii41 

    Neuronal transplantation is considered to be a promising therapeutic approach to neurodegenerative diseases. In addition to fetal tissues and neural stem cells, embryonic stem cells are good candidates for the creation of neurons. We have recently identified a stromal cell-derived inducing...

  • Stem cell see-saw. Margottini, Laura // New Scientist;4/6/2013, Vol. 217 Issue 2911, p31 

    The article reports that Italy's minister of health, Renato Balduzzi, has signed a legislative bill authorizing The Stamina Foundation to continue its administration of a controversial stem cell therapy on people with a range of degenerative diseases.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics